DISCOUNT ZERTIFIKAT - AMGEN | Market Closed - Börse Stuttgart 09:27:24 17/05/2024 pm IST | ||
| 256.8 EUR | -0.09% |
|
| Current month | +6.00% | ||
| 1 month | +8.26% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 17/24/17 | 256.8 | -0.09% |
| 16/24/16 | 257 | -0.20% |
| 15/24/15 | 257.6 | +0.17% |
| 14/24/14 | 257.1 | +0.06% |
| 13/24/13 | 257 | -0.25% |
Delayed Quote Börse Stuttgart
Last update May 17, 2024 at 09:27 pm IST
More quotesStatic data
| Product type | Discount Certificates |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Morgan Stanley |
| WKN | ME680U |
| ISIN | DE000ME680U8 |
| Date issued | 02/01/2024 |
| Maturity | 20/09/2024 (125 Days) |
| Parity | 1 : 1 |
| Emission price | 238.5 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 258 € |
|---|---|
| Lowest since issue | 233 € |
| Spread | 0.05 € |
| Spread % | 0.02% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
312.5
USD
Average target price
314.1
USD
Spread / Average Target
+0.51%
- Stock Market
- Certificates
- Certificat
